Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19 ...

With the latest COVID-19 surge, information on testing and vaccinations for those who are uninsured is becoming hard to find.

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Invivyd ( ($IVVD) ) just unveiled an update. On August 14, 2025, Invivyd announced its alignment with the U.S. FDA on a rapid pathway to full ...

The FDA says they are considering ending authorization for healthy children between 6 months and 5 years old. Melania Trump ...

The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

This explainer discusses what ACIP does, how it makes recommendations, and how administration actions may affect Americans’ ...

Doctors and public health leaders recommend that most people 6 months old and older get the 2025-26 flu vaccine ...